March 3, 2008 — Jazz Pharmaceuticals Inc has announced that it has received US Food and Drug Administration (FDA) approval for a once-daily extended-release formulation of fluvoxamine maleate ...

The FDA has approved revisions to the safety labeling for fluvoxamine maleate tablets, ritonavir soft gelatin capsules and oral solution (Norvir), and somatropin [rDNA origin] for injection (Tev ...

Co announces that the FDA has accepted for review the submission of the complete response by Solvay Pharmaceuticals to the FDA approvable letter for Luvox CR (fluvoxamine maleate) extended-release ...